Results 11 to 20 of about 156,103 (307)
Infant protection from invasive <i>Haemophilus influenzae</i> type b disease using the PRP-OMPC conjugate vaccine: An update. [PDF]
Hum Vaccin ImmunotherTaha MK +5 more
europepmc +2 more sources
Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules
BMC Infectious Diseases, 2021 Background Haemophilus influenzae serotype b (Hib) conjugate vaccine was introduced in France in 1992 as a 3 + 1 scheme at 2, 3, and 4 months (primary vaccination) with a booster at the age of 16–18 months. The vaccination was simplified in 2013 to a 2 +
Eva Hong +6 more
doaj +1 more source
npj Vaccines, 2022 Since January 2018, mandatory vaccination against meningococci serogroup C has been implemented in France for children
Samy Taha +2 more
doaj +1 more source
Product review on the IMD serogroup B vaccine Bexsero®
Human Vaccines & Immunotherapeutics, 2022 Bexsero® is a multicomponent vaccine composed of four major proteins of Neisseria meningitidis: the fHbp, NHBA, NadA and PorA. This vaccine was licensed against invasive meningococcal disease (IMD) due to serogroup B isolates.
Ala-Eddine Deghmane, Muhamed-Kheir Taha
doaj +1 more source
Frontiers in Microbiology, 2023 BackgroundNon-typeable Haemophilus influenzae has become increasingly important as a causative agent of invasive diseases following vaccination against H. influenzae type b.
Esra Ekinci +13 more
doaj +1 more source
Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease
BMC Research Notes, 2020 Objective Few data are available on the association between SARS-CoV-2 and secondary bacterial infections. Such an association was described for flu and invasive meningococcal disease (IMD).
Muhamed-Kheir Taha, Ala-Eddine Deghmane
doaj +1 more source
Haemophilus influenzae Carriage among Healthy Children in Portugal, 2015–2019
Microorganisms, 2022 Haemophilus influenzae is an important cause of mucosal and invasive infections and a common colonizer of the upper respiratory tract. As there are no recent data on H.
Maria Paula Bajanca-Lavado +6 more
doaj +1 more source
Haemophilus influenzae type b.
The Nurse Practitioner, 2020 119 8 Haemophilus influenzae is a cause of bacterial infections that are often severe, particularly among infants. It was first described by Pfeiffer in 1892.
Manika Suryadevara
semanticscholar +1 more source
Analysis of Haemophilus species in patients with respiratory tract infections in Yaoundé, Cameroon
International Journal of Infectious Diseases, 2020 Objectives: To identifyHaemophilus species and characterise the antimicrobial susceptibility of isolates from patients with respiratory tract infections (RTIs) in Cameroon.
Serges Tchatchouang +11 more
doaj +1 more source
European Respiratory Journal, 2020 Long-term azithromycin treatment reduced exacerbations in adults with persistent symptomatic asthma in the AMAZES trial (Australian and New Zealand Clinical Trials Registry (ANZCTR), number 12609000197235) [1]. However, response to treatment was variable
S. Taylor +4 more
semanticscholar +1 more source